Accelerate Diagnostics Inc (AXDX) CFO Steven Reichling Sold $911,656 of Shares

- By insider

CFO of Accelerate Diagnostics Inc (30-Year Financial, Insider Trades) Steven Reichling (insider trades) sold 70,671 shares of AXDX on 01/27/2021 at an average price of $12.9 a share. The total sale was $911,656.

• Warning! GuruFocus has detected 6 Warning Signs with AXDX. Click here to check it out.

• AXDX 15-Year Financial Data

• The intrinsic value of AXDX

• Peter Lynch Chart of AXDX

Accelerate Diagnostics Inc is an in vitro diagnostics company, dedicated in providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Accelerate Diagnostics Inc has a market cap of $855.159 million; its shares were traded at around $14.995000 with and P/S ratio of 72.43. GuruFocus has detected 4 severe warning signs with Accelerate Diagnostics Inc. .

CFO Recent Trades:

• CFO Steven Reichling sold 70,671 shares of AXDX stock on 01/27/2021 at the average price of $12.9. The price of the stock has increased by 16.24% since.

For the complete insider trading history of AXDX, click here

.This article first appeared on GuruFocus.